Researcher
Wouter Janssens
Affiliations
- Institute of Tropical Medicine (Research institute)
Member
From1 Jan 1992 → 17 Jul 2008
Publications
1 - 10 of 80
- Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof-of-concept clinical trial of new antivirals working against SARS-CoV-2-azithromycin trial(2021)
Authors: Iwein Gyselinck, Laurens Liesenborghs, Ewout Landeloos, Ann Belmans, Geert Verbeke, Peter Verhamme, Robin Vos, W Janssens
- Unravelling the antigenic landscape of the HIV-1 subtype A envelope of an individual with broad cross-neutralizing antibodies using phage display peptide libraries(2010)
Authors: T. Dieltjens, BART WILLEMS, Sandra Coppens, L. Van Nieuwenhove, M. Humbert, U Dietrich, Leo Heyndrickx, G Vanham, W Janssens
Pages: 95-102 - Presence of a multidrug-resistance mutation in an HIV-2 variant infecting a treatment-naive individual in Caio, Guinea Bissau(2009)
Authors: Sabelle Jallow, T Vincent, A Leligdowicz, T. de Silva, C Van Tienen, A Alabi, R Sarge-Njie, P Aaby, T. Corrah, H. Whittle, et al.
Pages: 1790-1793 - Virological response to highly active antiretroviral therapy in patients infected with human immunodeficiency virus type 2 (HIV-2) and in patients dually infected with HIV-1 and HIV-2 in The Gambia and emergence of drug-resistant variants(2009)
Authors: Sabelle Jallow, A Alabi, R Sarge-Njie, K. Peterson, H. Whittle, T. Corrah, A Jaye, M Cotten, Guido Vanham, SJ McConkey, et al.
Pages: 2200-2208 - HIV type 1 subtype A envelope genetic evolution in a slow progressing individual with consistent broadly neutralizing antibodies(2009)
Authors: T Dieltjens, Nathalie Loots, K Vereecken, K. Grupping, L Heyndrickx, Emmanuel Bottieau, Guido Vanham, D. Davis, W Janssens
Pages: 1165-1169 - Human immunodeficiency virus type 1 escape from cyclotriazadisulfonamide-induced CD4-targeted entry inhibition is associated with increased neutralizing antibody susceptibility(2009)
Authors: K Vermeire, K Van Laethem, Wouter Janssens, TW Bell, D Schols
Pages: 9577-9583 - Evolution of antibody landscape and viral envelope escape in an HIV-1 CRF02_AG infected patient with 4E10-like antibodies(2009)
Authors: T. Dieltjens, Leo Heyndrickx, BART WILLEMS, E Gray, L. Van Nieuwenhove, K. Grupping, G Vanham, W Janssens
Pages: 1-13 - Neutralization patterns and evolution of sequential HIV type 1 envelope sequences in HIV type 1 subtype B-infected drug-naive individuals(2008)
Authors: P Nyambi, S Burda, M Urbanski, L Heyndrickx, W Janssens, Guido Vanham, A Nadas
Pages: 1507-1519 - Optimization of the oligonucleotide ligation assay, a rapid and inexpensive test for detection of HIV-1 drug resistance mutations, for non-north American variants(2008)
Authors: IA Beck, C Crowell, R Kittoe, H Bredell, M Machaba, C Willamson, W Janssens, Sabelle Jallow, Guido Van Der Groen, Y Shao, et al.
Pages: 418-427 - Development and evaluation of an oligonucleotide ligation assay for detection of drug resistance-associated mutations in the human immunodeficiency virus type 2 pol gene(2007)
Authors: Sabelle Jallow, S Kaye, M Schutten, E Brandin, J Albert, SJ McConkey, T. Corrah, H. Whittle, Guido Vanham, S. Rowland-Jones, et al.
Pages: 1565-1571